Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 1/20 | 0.32 |
| ▸ | FHIT | P49789 | 2/20 | 0.31 |
| ▸ | RNASEL | Q05823 | 5/20 | 0.31 |
| ▸ | DTYMK | P23919 | 2/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20691956 | 0.84 | RNASEL (0.40) | RNASELDTYMKENPP1 | |
| SCHEMBL24680655 | 0.71 | NT5E (0.40) | FHITRNASELDTYMK | |
| SCHEMBL22349197 | 0.70 | DTYMK (0.42) | DTYMKENPP1 | |
| SCHEMBL20691322 | 0.68 | POLB (0.41) | DTYMKENPP1 | |
| SCHEMBL20692011 | 0.67 | ALDH1A1 (0.37) | IMPDH2IMPDH1 | |
| SCHEMBL24060484 | 0.67 | RNASEL (0.45) | RNASELDTYMK | |
| SCHEMBL24258651 | 0.66 | RNASEL (0.45) | RNASEL | |
| SCHEMBL20691405 | 0.65 | DTYMK (0.41) | RNASELDTYMKENPP1 | |
| SCHEMBL20691965 | 0.65 | RNASEL (0.45) | FHITRNASELENPP1 | |
| SCHEMBL22340326 | 0.65 | POLB (0.42) | FHITDTYMKENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3658565-B1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2022-11-09 | — | — | EP | disclosed |
| WO-2019023459-A1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-01-31 | — | — | WO | disclosed |